Cargando…
COVID-19 Disease and Vitamin D: A Mini-Review
Novel coronavirus disease (COVID-19) pandemic caused by SARS-CoV-2, for which there is no effective treatment except employing prevention strategies, has already instituted significant number of deaths. In this review, we provide a scientific view on the potential role of vitamin D in SARS-CoV-2 vir...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773655/ https://www.ncbi.nlm.nih.gov/pubmed/33390994 http://dx.doi.org/10.3389/fphar.2020.604579 |
_version_ | 1783630090621419520 |
---|---|
author | Boulkrane, Mohamed Said Ilina, Victoria Melchakov, Roman Fedotova, Julia Drago, Filippo Gozzo, Lucia Das, Undurti Narasimha Abd El-Aty, A. M. Baranenko, Denis |
author_facet | Boulkrane, Mohamed Said Ilina, Victoria Melchakov, Roman Fedotova, Julia Drago, Filippo Gozzo, Lucia Das, Undurti Narasimha Abd El-Aty, A. M. Baranenko, Denis |
author_sort | Boulkrane, Mohamed Said |
collection | PubMed |
description | Novel coronavirus disease (COVID-19) pandemic caused by SARS-CoV-2, for which there is no effective treatment except employing prevention strategies, has already instituted significant number of deaths. In this review, we provide a scientific view on the potential role of vitamin D in SARS-CoV-2 virus/COVID-19 disease. Vitamin D is well-known to play a significant role in maintaining the immune health of an individual. Moreover, it induces antimicrobial peptide expression that can decrease viral replication and regulate the levels of pro-inflammatory/anti-inflammatory cytokines. Therefore, supplementation of vitamin D has the potential to reduce the incidence, severity and the risk of death from pneumonia resulting from the cytokine storm of many viral infections including COVID-19. We suggest that supplementation of subjects at high risk of COVID-19 with vitamin D (1.000 to 3.000 IU) to maintain its optimum serum concentrations may be of significant benefit for both in the prevention and treatment of the COVID-19. |
format | Online Article Text |
id | pubmed-7773655 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-77736552021-01-01 COVID-19 Disease and Vitamin D: A Mini-Review Boulkrane, Mohamed Said Ilina, Victoria Melchakov, Roman Fedotova, Julia Drago, Filippo Gozzo, Lucia Das, Undurti Narasimha Abd El-Aty, A. M. Baranenko, Denis Front Pharmacol Pharmacology Novel coronavirus disease (COVID-19) pandemic caused by SARS-CoV-2, for which there is no effective treatment except employing prevention strategies, has already instituted significant number of deaths. In this review, we provide a scientific view on the potential role of vitamin D in SARS-CoV-2 virus/COVID-19 disease. Vitamin D is well-known to play a significant role in maintaining the immune health of an individual. Moreover, it induces antimicrobial peptide expression that can decrease viral replication and regulate the levels of pro-inflammatory/anti-inflammatory cytokines. Therefore, supplementation of vitamin D has the potential to reduce the incidence, severity and the risk of death from pneumonia resulting from the cytokine storm of many viral infections including COVID-19. We suggest that supplementation of subjects at high risk of COVID-19 with vitamin D (1.000 to 3.000 IU) to maintain its optimum serum concentrations may be of significant benefit for both in the prevention and treatment of the COVID-19. Frontiers Media S.A. 2020-12-17 /pmc/articles/PMC7773655/ /pubmed/33390994 http://dx.doi.org/10.3389/fphar.2020.604579 Text en Copyright © 2020 Boulkrane, Ilina, Melchakov, Fedotova, Drago, Gozzo, Das, Abd El-Aty and Baranenko http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Boulkrane, Mohamed Said Ilina, Victoria Melchakov, Roman Fedotova, Julia Drago, Filippo Gozzo, Lucia Das, Undurti Narasimha Abd El-Aty, A. M. Baranenko, Denis COVID-19 Disease and Vitamin D: A Mini-Review |
title | COVID-19 Disease and Vitamin D: A Mini-Review |
title_full | COVID-19 Disease and Vitamin D: A Mini-Review |
title_fullStr | COVID-19 Disease and Vitamin D: A Mini-Review |
title_full_unstemmed | COVID-19 Disease and Vitamin D: A Mini-Review |
title_short | COVID-19 Disease and Vitamin D: A Mini-Review |
title_sort | covid-19 disease and vitamin d: a mini-review |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773655/ https://www.ncbi.nlm.nih.gov/pubmed/33390994 http://dx.doi.org/10.3389/fphar.2020.604579 |
work_keys_str_mv | AT boulkranemohamedsaid covid19diseaseandvitamindaminireview AT ilinavictoria covid19diseaseandvitamindaminireview AT melchakovroman covid19diseaseandvitamindaminireview AT fedotovajulia covid19diseaseandvitamindaminireview AT dragofilippo covid19diseaseandvitamindaminireview AT gozzolucia covid19diseaseandvitamindaminireview AT dasundurtinarasimha covid19diseaseandvitamindaminireview AT abdelatyam covid19diseaseandvitamindaminireview AT baranenkodenis covid19diseaseandvitamindaminireview |